Karl Friston joins VERSES as Chief Scientist to Lead New Era in Artificial Intelligence
December 01 2022 - 8:00AM
VERSES Technologies Inc. (NEO:VERS) (OTCQX:VRSSF) ("VERSES'' or the
"Company”), a cognitive computing company specializing in the next
generation of Artificial Intelligence (AI) systems, announced today
that Dr. Karl Friston, Professor of Neuroscience at University
College London, Scientific Director of the Wellcome Trust Centre
for Neuroimaging, and one of the world’s leading and most cited
scientists in the study of the brain and mind (i.e., Computational
Neuroscience and Artificial Intelligence), has joined the Company
as its Chief Scientist to direct and oversee the Company’s advanced
AI research and development.
Friston’s world-leading expertise in the development and
application of Active Inference, which approaches the design of
intelligent systems using design principles from nature (i.e., the
physics and neurobiology of information processing), will be
central to the R&D of the class of next-generation AI systems
being developed at VERSES. The first output of his tenure as Chief
Scientist of VERSES AI Research Lab, which is directed by Dr.
Maxwell Ramstead, will be a White Paper that will propose a novel
approach to addressing the current limitations of AI and offer a
multi-stage roadmap toward enabling the “holy grail” of AI known as
Artificial General Intelligence (AGI).
“It is with great enthusiasm and excitement that we welcome Karl
Friston to VERSES as our Chief Scientist,” said Gabriel René,
Founder, and CEO of VERSES. “Dr. Friston’s breakthrough work in
neuroscience and biologically-inspired AI, known as Active
Inference, aligns beautifully with our vision and mission to enable
a “smarter world” where AI powers the applications of the 21st
century. As the originator of this principle, it is only fitting
that Karl has a significant role in VERSES AI research and
development all the way through their applied uses in product
commercialization.”
Friston who was ranked #1 most influential neuroscientist in the
world by Semantic Scholar in 2016 has had an illustrious and
decorated scientific career. He became a Fellow of the Royal
Society in 2006 and The Royal Society of Biology in 2012, received
the Weldon Memorial Prize and Medal in 2013 for his remarkable
contributions to mathematical biology and was elected as a member
of EMBO in 2014 and the Academia Europaea in 2015. He was the 2016
recipient of the Charles Branch Award for unparalleled
breakthroughs in Brain Research and the Glass Brain Award from the
Organization for Human Brain Mapping. He holds Honorary doctorates
from the universities of York, Zurich, Liège, and Radboud
University. “I am delighted and honored to join VERSES. I have
seldom met such a friendly, focused, committed, and right-minded
group of colleagues. On a personal note, my appointment as Chief
Scientist is exactly the kind of dénouement of my academic career I
had hoped for – a dénouement that marks the beginning of a new and
exciting journey of discovery and enabling,” said Karl Friston.
“I am genuinely delighted to be working alongside Karl Friston
at VERSES,” said Maxwell Ramstead, Director of Research at VERSES.
“This is an opportunity to introduce Active Inference to a broader
audience and highlight the significant role that we believe it will
have in the development of the next generation of Artificial
Intelligence systems. The application of Active Inference to
Artificial Intelligence marks a shift in the development of
intelligent synthetic systems, drawing inspiration and design
principles from the way that the brain, nervous system, and body
act and react. We believe that it will bring about a paradigm shift
in AI.”
VERSES will publish its research paper to arxiv.org in early
December and plans to host a Webinar to explore the applications
and implications of Active Inference on the future of Artificial
Intelligence.
This article uses material from the Wikipedia article on <a
target="_blank"
href="https://en.wikipedia.org/wiki/Karl_J._Friston">"Karl J.
Friston"</a>, which is released under the <a
target="_blank"
href="https://creativecommons.org/licenses/by-sa/3.0/"> Creative
Commons Attribution-Share-Alike License 3.0</a>.
About VERSESVERSES is a cognitive computing
company specializing in next-generation Artificial Intelligence.
Modeled after natural systems and the design principles of the
human brain and the human experience, VERSES' flagship offering,
KOSM™, is a network operating system for enhancing any application
with adaptive intelligence. Built on open standards, KOSM
transforms disparate data into a universal context that fosters
trustworthy collaboration between humans, machines, and AI, across
digital and physical domains. Imagine a smarter world that elevates
human potential through innovations inspired by nature. Learn more
at VERSES, LinkedIn, and Twitter.
On Behalf of the Company Gabriel RenéVERSES
Technologies Inc.Co-Founder & CEOpress@verses.ioMedia
and Investor Relations Inquiries Leo KarabelasFocus
CommunicationsPresidentinfo@fcir.ca416-543-3120
NEO Exchange has not reviewed or approved this press release for
the adequacy or accuracy of its contents.
Forward-Looking Statements Cautionary Note
This release includes certain statements and information that
may constitute forward-looking information within the meaning of
applicable Canadian securities laws. Forward-looking statements
relate to future events or future performance and reflect the
expectations or beliefs of management of the Company regarding
future events. Generally, forward-looking statements and
information can be identified by the use of forward-looking
terminology such as “intends” or “anticipates,” or variations of
such words and phrases or statements that certain actions, events
or results “may,” “could,” “should,” “would” or “occur”. This
information and these statements, referred to herein as
"forward-looking statements", are not historical facts, are made as
of the date of this news release and include without limitation,
statements regarding discussions of future plans, estimates and
forecasts and statements as to management's expectations and
intentions with respect to, among other things, Active Inference
being central to VERSES’ future research and development and White
Paper and research paper deliverables on Artificial Intelligence
and Active Inference. In making the forward-looking statements in
this news release, the Company has applied several material
assumptions, including without limitation, that the Company will be
able to execute on its research and development plans and that the
Company’s research and development plans will not be adversely
impacted by COVID-19 or the ongoing conflict in Eastern Europe.
These forward-looking statements involve numerous risks and
uncertainties, and actual results might differ materially from
results suggested in any forward-looking statements. These risks
and uncertainties include, among other things, risks relating to
the Company being unable to execute on its research and development
plans, the impact of technological inefficiencies, cyber security
attacks, adverse changes in legislation relating to the digital
twin market, increase in competition, the volatility of global
capital markets, political instability, the lack of access to
capital or financing when required, the loss of key personnel,
technology or software disruptions, unanticipated costs, risks
related to the COVID-19 pandemic, risks relating to the extent and
duration of the conflict in Eastern Europe and its impact on global
markets and other risk factors disclosed in the Company’s
disclosure record on www.sedar.com under the Company’s profile.
Although management of the Company has attempted to identify
important factors that could cause actual results to differ
materially from those contained in forward-looking statements or
forward-looking information, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking statements and
forward-looking information. Readers are cautioned that reliance on
such information may not be appropriate for other purposes. The
Company does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws.
ProShares Trust (NYSE:VERS)
Historical Stock Chart
From Jun 2024 to Jul 2024
ProShares Trust (NYSE:VERS)
Historical Stock Chart
From Jul 2023 to Jul 2024